OR WAIT null SECS
This FAQ is a printable reference for ob/gyns. It features information on the COVID-19 vaccines, as well as frequently asked questions and answers for ob/gyns to use when counseling patients.
Currently, the two available vaccines for coronavirus disease 2019 are messenger RNA (mRNA) vaccines. This type of vaccine teaches cells how to make a protein, starting an immune response that creates antibodies. The antibodies protect us from getting infected when exposed to COVID-19.
The COVID-19 vaccine is different than influenza, or other vaccines, that rely on either live or inactivated virus to create the immune response.
Download the printable PDF here:
1. Polack FP, Thomas SJ, Kitchin N, et al. C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. N Engl J Med. Published online Dec 10, 2020: NEJMoa2034577. doi:10.1056/ NEJMoa2034577. PMID: 33301246; PMCID: PMC7745181.
2. The United States Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee Meeting, Dec. 17, 2020. Accessed Dec. 21, 2020. https://www.fda.gov/media/144434/download
3. The American College of Obstetricians and Gynecologists. Vaccinating Pregnant and Lactating Patients Against COVID-19. Accessed online Dec. 21, 2020.
4. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020. MMWR
Morb Mortal Wkly Rep. Dec. 18, 2020;69(50):1922-1924. doi:10.15585/mmwr.mm6950e2. PMID: 33332292.
5. Wambier CG, Vaño-Galván S, McCoy J, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”. J Am Acad Dermatol. August 2020;83(2):680-682. doi:10.1016/j.jaad.2020.05.079. Epub May 22, 2020. PMID: 32446821; PMCID: PMC7242206.